AstraZeneca Plc will license Japanese biotechnology company JCR Pharmaceutical, to produce some 90 million doses of its COVID-19 vaccine to help Japan avoid shortages and delays, the Nikkei newspaper …
( read original story …)
The Japan News
AstraZeneca Plc will license Japanese biotechnology company JCR Pharmaceutical, to produce some 90 million doses of its COVID-19 vaccine to help Japan avoid shortages and delays, the Nikkei newspaper …
( read original story …)